IBEX Pharmaceuticals Overview
- Year Founded
-
1972
- Status
-
Acquired/Merged
- Employees
-
20
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
- Investments
-
3
IBEX Pharmaceuticals General Information
Description
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.
Contact Information
Website
www.ibexpharma.com(Operating Subsidiary)
Corporate Office
- 5485 Rue Pare
- Suite 100
- Montreal, Quebec H4P 1P7
- Canada
Corporate Office
- 5485 Rue Pare
- Suite 100
- Montreal, Quebec H4P 1P7
- Canada
IBEX Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
IBEX Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
IBEX Pharmaceuticals Patents
IBEX Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20120325715-A1 | Crumple zone package for moisture sensitive products | Inactive | 31-May-2011 | ||
| CA-2741854-A1 | Crumple zone package for moisture sensitive products | Inactive | 31-May-2011 | ||
| CA-2777965-A1 | Crumple zone package for moisture sensitive products | Inactive | 31-May-2011 | ||
| US-20060287231-A1 | Therapeutic uses of kallikreins | Inactive | 18-May-2005 | ||
| EP-1263459-A2 | Attenuation of fibroblast proliferation | Inactive | 02-Dec-1999 | A61K38/51 |
IBEX Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
IBEX Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
IBEX Pharmaceuticals Acquisitions (3)
IBEX Pharmaceuticals’s most recent deal was a Merger/Acquisition with Bio-Research Products for . The deal was made on 31-Dec-2012.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Bio-Research Products | 31-Dec-2012 | Merger/Acquisition | Biotechnology | ||
| Garvinci | 07-May-2007 | Merger/Acquisition | Personal Products | ||
| OncoTherapeutics | 07-May-2003 | Merger/Acquisition | BPO/Outsource Services |
IBEX Pharmaceuticals Exits (1)
IBEX Pharmaceuticals’s most recent exit was on 07-May-2003 from OncoTherapeutics. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| OncoTherapeutics | 07-May-2003 | Completed |
|
IBEX Pharmaceuticals FAQs
-
When was IBEX Pharmaceuticals founded?
IBEX Pharmaceuticals was founded in 1972.
-
Where is IBEX Pharmaceuticals headquartered?
IBEX Pharmaceuticals is headquartered in Montreal, Canada.
-
What is the size of IBEX Pharmaceuticals?
IBEX Pharmaceuticals has 20 total employees.
-
What industry is IBEX Pharmaceuticals in?
IBEX Pharmaceuticals’s primary industry is Medical Supplies.
-
Is IBEX Pharmaceuticals a private or public company?
IBEX Pharmaceuticals is a Private company.
-
What is the current valuation of IBEX Pharmaceuticals?
The current valuation of IBEX Pharmaceuticals is .
-
What is IBEX Pharmaceuticals’s current revenue?
The current revenue for IBEX Pharmaceuticals is .
-
Who are IBEX Pharmaceuticals’s investors?
Clairvest Group has invested in IBEX Pharmaceuticals.
-
When was IBEX Pharmaceuticals acquired?
IBEX Pharmaceuticals was acquired on 08-Apr-2024.
-
Who acquired IBEX Pharmaceuticals?
IBEX Pharmaceuticals was acquired by BBI Solutions.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
